| Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight WE Wysokinski, DA Froehling, DE Houghton, RD McBane, DT Vlazny, ... European Journal of Haematology 105 (4), 484-494, 2020 | 21 | 2020 |
| Calf vein thrombosis comparison of outcomes for axial and muscular venous thrombosis W Kuczmik, WE Wysokinski, GK Hesley, DT Vlazny, DE Houghton, ... Thrombosis and haemostasis 121 (02), 216-223, 2021 | 20 | 2021 |
| Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis DT Vlazny, AK Pasha, W Kuczmik, WE Wysokinski, M Bartlett, D Houghton, ... Journal of Thrombosis and Haemostasis 19 (9), 2206-2215, 2021 | 14 | 2021 |
| Calf vein thrombosis outcomes comparing anticoagulation and serial ultrasound imaging management strategies W Kuczmik, WE Wysokinski, T Macedo, D Froehling, P Daniels, ... Mayo Clinic Proceedings 96 (5), 1184-1192, 2021 | 9 | 2021 |
| Computerized differentiation of growth status for abdominal aortic aneurysms: a feasibility study M Rezaeitaleshmahalleh, KW Sunderland, Z Lyu, T Johnson, K King, ... Journal of cardiovascular translational research 16 (4), 874-885, 2023 | 7 | 2023 |
| Cancer‐associated non‐bacterial thrombotic endocarditis—Clinical series from a single institution P Patrzalek, WE Wysokinski, RD Kurmann, D Houghton, D Hodge, ... American Journal of Hematology, 2024 | 3 | 2024 |
| Calf vein thrombosis outcomes comparing patients with and without cancer AK Pasha, W Kuczmik, WE Wysokinski, AI Casanegra, D Houghton, ... Journal of Thrombosis and Thrombolysis 51, 1059-1066, 2021 | 3 | 2021 |
| Autoimmune Hepatitis—Challenging Diagnosis A Mroskowiak, A Suleja, M Stec, W Kuczmik, M Migacz, M Holecki Medicina 58 (7), 896, 2022 | 2 | 2022 |
| ARNI in HFrEF—One-Centre Experience in the Era before the 2021 ESC HF Recommendations R Niemiec, I Morawska, M Stec, W Kuczmik, AS Swinarew, A Stanula, ... International Journal of Environmental Research and Public Health 19 (4), 2089, 2022 | 2 | 2022 |
| Hypertrophic cardiomyopathy, non-compaction cardiomyopathy or non-compaction phenotype—another diagnosis, other further treatment A Bednarek, M Stec, M Mizia-Szubryt, M Cichoń, W Kuczmik, K Mizia-Stec Kardiologia Polska (Polish Heart Journal) 79 (6), 700-701, 2021 | 1 | 2021 |
| Comparison of course of infections and antibiotherapy in patients with and without diabetes mellitus–one center experience M Stec, A Suleja, W Kuczmik, A Mroskowiak, M Migacz, M Holecki Annales Academiae Medicae Silesiensis 77 (1), 217-225, 2023 | | 2023 |
| Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy M Stec, A Suleja, D Gondko, W Kuczmik, J Roman, D Dziadosz, K Szydło, ... Journal of Clinical Medicine 12 (13), 4484, 2023 | | 2023 |
| Wieloetapowe hybrydowe leczenie rozwarstwiającego tętniaka aorty piersiowo-brzusznej W Kuczmik, A Suleja, K Magiera, M Juśko, P Kasprzak, W Kuczmik Chirurgia Polska 24 (1-2), 40-46, 2022 | | 2022 |
| Stent-graft 5-branch’owy jako terapia z wyboru u pacjenta z przeciekiem typu IA po implantacji stent-graftu z „kominem” do tętnicy nerkowej w terapii tętniaka podnerkowego … M Stec, W Kuczmik, A Suleja, P Kasprzak, W Kuczmik Chirurgia Polska 24 (1-2), 31-35, 2022 | | 2022 |
| Embolizacja dodatkowych tętnic odchodzących od aorty jako profilaktyka przecieku typu II u chorych z implantowanym stent-graftem branchowym A Suleja, W Kuczmik, M Stec, M Juśko, W Kuczmik Polish Surgery 23, 1-2, 2021 | | 2021 |
| Leczenie wewnątrznaczyniowe tętniaka rozwarstwiającego aorty piersiowo-brzusznej w przebiegu zespołu Marfana W Kuczmik, M Stec, A Suleja, W Kuczmik Chirurgia Polska 22 (1-2), 29-34, 2020 | | 2020 |
